About Zipline
Zipline was founded in 2014 by Keller Rinaudo Cliffton, Keenan Wyrobek, and Will Hetzler, based on the recognition that many regions, particularly in parts of Africa and other developing areas with limited road infrastructure, faced significant challenges reliably and quickly delivering critical medical supplies such as blood for transfusions, vaccines, and other time-sensitive medical products to healthcare facilities, especially those located in more remote areas where poor road conditions could make ground transportation slow, unreliable, or impractical, particularly during medical emergencies where delivery speed can be genuinely life-or-death.
Zipline's autonomous drone delivery system uses fixed-wing drones capable of covering significantly longer distances than the smaller, shorter-range delivery drones many other drone delivery companies have developed, launched from centralized distribution centers and capable of delivering packages, including medical supplies, to healthcare facilities across a substantial service radius, with the drones dropping packages using a small parachute rather than requiring a full landing, letting them serve locations without dedicated drone landing infrastructure. The company built its earliest and most extensive operational experience delivering blood, vaccines, and other medical supplies in Rwanda and Ghana, establishing what became, at the time, some of the world's most extensive routine commercial drone delivery operations, demonstrating the technology's practical viability at meaningful operational scale in real-world healthcare delivery contexts well before drone delivery achieved comparable operational scale in the United States or other wealthy countries, where regulatory approval processes for autonomous drone operations over populated areas have generally moved more cautiously. Zipline has since expanded into additional countries and use cases, including U.S. operations delivering retail goods, food, and other products in partnership with various retail and healthcare companies, applying lessons learned from its extensive African medical delivery operations to these newer commercial delivery contexts. The company has raised very substantial venture funding from investors including Alphabet's growth fund CapitalG, Baillie Gifford, and Katalyst Ventures, reaching a prior financing valuation exceeding $4.2 billion.
